MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$17,780K
Net Income
-$1,172K
Net Profit Margin
-6.59%
Unit: Thousand (K) dollars
Revenue Breakdown
cost of sales
gross profit
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
17,780
17,336
18,346
15,927
Cost of sales
14,537
14,439
14,468
13,655
Gross profit
3,243
2,897
3,878
2,272
Research and product development
40
-
0
0
Selling and marketing
577
567
540
531
General and administrative
3,687
3,810
3,736
3,325
Operating loss
-1,061
-1,480
-398
-1,584
Realized gain on available-for-sale investments
130
120
86
61
Interest expense
281
282
286
285
Interest income
40
37
44
55
Total other expense, net
-111
-125
-156
-169
Net loss
-1,172
-1,605
-554
-1,753
Basic EPS
-0.34
-0.04
-0.014
-0.05
Diluted EPS
-
-0.04
-0.014
-0.05
Basic Average Shares
3,958,568
39,418,302
39,453,038
36,024,940
Diluted Average Shares
3,958,568
39,418,302
39,453,038
36,024,940
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
cost of sales
$14,537K
(7.14%↑ Y/Y)
gross profit
$3,243K
(29.56%↑ Y/Y)
Net loss
-$1,172K
(21.45%↑ Y/Y)
Net sales
$17,780K
(10.63%↑ Y/Y)
Operating loss
-$1,061K
(21.35%↑ Y/Y)
Total other expense,
net
-$111K
(22.38%↑ Y/Y)
Gross profit
$3,243K
(29.56%↑ Y/Y)
Realized gain on
available-for-sale investments
$130K
(103.13%↑ Y/Y)
Interest income
$40K
(-42.03%↓ Y/Y)
Cost of sales
$14,537K
(7.14%↑ Y/Y)
General and
administrative
$3,687K
(12.41%↑ Y/Y)
Interest expense
$281K
(1.81%↑ Y/Y)
Selling and marketing
$577K
(0.87%↑ Y/Y)
Research and product
development
$40K
Buy us a coffee
ROCKWELL MEDICAL, INC. (RMTI)
ROCKWELL MEDICAL, INC. (RMTI)